Fundraising Fox
Phathom Pharmaceuticals
Founded 2018 · 436 employees on LinkedIn · 5 known investors
Find your way into Phathom Pharmaceuticals
Sign up to see every warm intro you have to Phathom Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Phathom Pharmaceuticals team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Phathom Pharmaceuticals is a pharmaceutical company that develops and markets prescription treatments, including VOQUEZNA (vonoprazan) for gastrointestinal conditions, in the U.S. market.
Founders & leadership
Investors · 5
How we know: Catalys Pacific's portfolio page · Not right? Tell us
How we know: Frazier Life Sciences's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
In the news
Frequently asked questions
- What does Phathom Pharmaceuticals do?
- Phathom Pharmaceuticals is a pharmaceutical company that develops and markets prescription treatments, including VOQUEZNA (vonoprazan) for gastrointestinal conditions, in the U.S. market.
- Who are Phathom Pharmaceuticals's investors?
- Phathom Pharmaceuticals's investors include Catalys Pacific, Frazier Life Sciences, New Enterprise Associates (NEA), Astellas Venture Management LLC, Medicxi.